FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996878421> ?p ?o ?g. }

• W1996878421 endingPage "551" @default.
• W1996878421 startingPage "545" @default.
• W1996878421 abstract "Objective There are no data on the relationship between serum paraoxonase-3 (PON3) concentration and atherosclerosis in humans. Our aim was to investigate possible associations, using recently developed methods, in patients with peripheral artery disease (PAD) or coronary artery disease (CAD). Methods We studied 118 PAD and 72 CAD patients and 175 healthy volunteers. Serum PON3 was determined by in-house ELISA using polyclonal antibodies generated against a synthetic peptide with a sequence specific to PON3. Polymorphisms of the PON3 promoter were analysed by the Iplex Gold MassArray™ method. Results There was a significant increase in serum PON3 concentration in both groups of patients with respect to the control group. In PAD patients, we observed significant positive correlations between PON3, insulin levels and HOMA index. These associations were not observed in CAD. There were significant positive associations between serum PON3 and β-2-microglobulin, CCL2 and high-sensitivity C-reactive protein in CAD patients, but not in PAD. We did not find any significant differences in PON3 gene promoter polymorphisms and their haplotypes between patients and controls, indicating that associations were not genetically determined. Conclusion In both atherosclerotic phenotypes, serum PON3 concentration was increased, but this was associated with decreased insulin sensitivity in PAD and with inflammation in CAD." @default.
• W1996878421 created "2016-06-24" @default.
• W1996878421 creator A5005699800 @default.
• W1996878421 creator A5007710630 @default.
• W1996878421 creator A5037174678 @default.
• W1996878421 creator A5039915561 @default.
• W1996878421 creator A5041551879 @default.
• W1996878421 creator A5053780005 @default.
• W1996878421 creator A5065691817 @default.
• W1996878421 creator A5066379335 @default.
• W1996878421 creator A5066399096 @default.
• W1996878421 creator A5082361809 @default.
• W1996878421 creator A5085891378 @default.
• W1996878421 creator A5088797858 @default.
• W1996878421 creator A5090251071 @default.
• W1996878421 date "2012-02-01" @default.
• W1996878421 modified "2023-10-18" @default.
• W1996878421 title "Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery disease" @default.
• W1996878421 cites W1967959177 @default.
• W1996878421 cites W1968302053 @default.
• W1996878421 cites W1985954107 @default.
• W1996878421 cites W1987761929 @default.
• W1996878421 cites W1989425675 @default.
• W1996878421 cites W1995568914 @default.
• W1996878421 cites W1998875272 @default.
• W1996878421 cites W2004725085 @default.
• W1996878421 cites W2008950006 @default.
• W1996878421 cites W2014410152 @default.
• W1996878421 cites W2014874996 @default.
• W1996878421 cites W2016568050 @default.
• W1996878421 cites W2037197890 @default.
• W1996878421 cites W2063944937 @default.
• W1996878421 cites W2065175310 @default.
• W1996878421 cites W2087736738 @default.
• W1996878421 cites W2091239817 @default.
• W1996878421 cites W2099040294 @default.
• W1996878421 cites W2101154649 @default.
• W1996878421 cites W2122891093 @default.
• W1996878421 cites W2128385760 @default.
• W1996878421 cites W2136843963 @default.
• W1996878421 cites W2151426663 @default.
• W1996878421 cites W2160234571 @default.
• W1996878421 cites W2162530578 @default.
• W1996878421 cites W2163176471 @default.
• W1996878421 cites W2166691340 @default.
• W1996878421 cites W2171308395 @default.
• W1996878421 cites W2319591784 @default.
• W1996878421 cites W89653608 @default.
• W1996878421 doi "https://doi.org/10.1016/j.atherosclerosis.2011.11.021" @default.
• W1996878421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22153698" @default.
• W1996878421 hasPublicationYear "2012" @default.
• W1996878421 type Work @default.
• W1996878421 sameAs 1996878421 @default.
• W1996878421 citedByCount "24" @default.
• W1996878421 countsByYear W19968784212013 @default.
• W1996878421 countsByYear W19968784212014 @default.
• W1996878421 countsByYear W19968784212015 @default.
• W1996878421 countsByYear W19968784212016 @default.
• W1996878421 countsByYear W19968784212017 @default.
• W1996878421 countsByYear W19968784212018 @default.
• W1996878421 countsByYear W19968784212019 @default.
• W1996878421 countsByYear W19968784212020 @default.
• W1996878421 countsByYear W19968784212021 @default.
• W1996878421 countsByYear W19968784212022 @default.
• W1996878421 countsByYear W19968784212023 @default.
• W1996878421 crossrefType "journal-article" @default.
• W1996878421 hasAuthorship W1996878421A5005699800 @default.
• W1996878421 hasAuthorship W1996878421A5007710630 @default.
• W1996878421 hasAuthorship W1996878421A5037174678 @default.
• W1996878421 hasAuthorship W1996878421A5039915561 @default.
• W1996878421 hasAuthorship W1996878421A5041551879 @default.
• W1996878421 hasAuthorship W1996878421A5053780005 @default.
• W1996878421 hasAuthorship W1996878421A5065691817 @default.
• W1996878421 hasAuthorship W1996878421A5066379335 @default.
• W1996878421 hasAuthorship W1996878421A5066399096 @default.
• W1996878421 hasAuthorship W1996878421A5082361809 @default.
• W1996878421 hasAuthorship W1996878421A5085891378 @default.
• W1996878421 hasAuthorship W1996878421A5088797858 @default.
• W1996878421 hasAuthorship W1996878421A5090251071 @default.
• W1996878421 hasConcept C126322002 @default.
• W1996878421 hasConcept C134018914 @default.
• W1996878421 hasConcept C164705383 @default.
• W1996878421 hasConcept C2776151105 @default.
• W1996878421 hasConcept C2776509667 @default.
• W1996878421 hasConcept C2776914184 @default.
• W1996878421 hasConcept C2778213512 @default.
• W1996878421 hasConcept C555293320 @default.
• W1996878421 hasConcept C71924100 @default.
• W1996878421 hasConceptScore W1996878421C126322002 @default.
• W1996878421 hasConceptScore W1996878421C134018914 @default.
• W1996878421 hasConceptScore W1996878421C164705383 @default.
• W1996878421 hasConceptScore W1996878421C2776151105 @default.
• W1996878421 hasConceptScore W1996878421C2776509667 @default.
• W1996878421 hasConceptScore W1996878421C2776914184 @default.
• W1996878421 hasConceptScore W1996878421C2778213512 @default.
• W1996878421 hasConceptScore W1996878421C555293320 @default.
• W1996878421 hasConceptScore W1996878421C71924100 @default.
• W1996878421 hasIssue "2" @default.

• next